A Study of ADRX-0706 in Select Advanced Solid Tumors

Clinical trial NCT06036121 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06036121
Sponsor: Adcentrx Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Triple Negative Breast Cancer (TNBC)Urothelial Cancer Cervical Cancer

Start date: 2023-09-26
Primary completion: 2025-09-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.